THE Intellectual Property Office of the Philippines (Ipophl) disputed the United States Trade Representative's (USTR) claim that the Philippines may be a producer of fake medicines.
In a statement, the country's copyright regulator said the USTR based its claim on reports from the Organization for Economic Cooperation and Development (OECD) and the European Union IP Office (EUIPO), which referred to countries like the Philippines as "provenance economies."
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.